The variation in stomach cancer incidence between MLH1 and MSH2 carriers may be attributed to age-specific hazard ratio (HR) differences, a younger onset for MLH1 carriers, or a higher representation of MLH1 mutations among gastric cancer cases (21). This evidence concerns the gene MSH2 and gastric neoplasm.